Blue Star Q2FY27 slides: revenue surges 21%, margins face pressure

Blue Star’s Q2FY27 revenue rose 21% year over year to ₹2,930.95 crore, but EBITDA grew only 10.5% to ₹202.58 crore as material-cost inflation squeezed margins. Unitary Products EBIT margin fell 390 bps to 2.3%, while the Electro-Mechanical segment’s margin declined 190 bps to 6.9%; Q2 net profit rose 25.4% to ₹123.91 crore but included a ₹23.02 crore MedTech-sale gain. H1FY27 EBITDA fell 1.5%, although the company swung from ₹417.06 crore net borrowings to ₹289.43 crore net cash; management sees potential to double data-center revenue from about ₹2,000 crore to ₹4,000 crore by FY2030.

Analysis

The key issue is earnings quality, not demand: volume growth is currently converting poorly into core profit. Room-AC overcapacity limits price recovery, so a longer cooling season can pull demand forward without fixing unit economics; a softer post-summer period could expose inventory and discounting pressure. Project execution delays and a modest order-book increase relative to sales also weaken the case that near-term growth is broadly accelerating.

The cash swing improves resilience, but asset-sale proceeds mean investors should verify how much reflects recurring operating cash generation before capitalizing it as a durable balance-sheet change. Likewise, the standout industrial-segment margin is not a clean run-rate signal because the warranty write-back is non-recurring. Data centers and manufacturing facilities offer a plausible 6–18-month mix improvement, but the FY2030 ambition should receive little credit until orders convert to revenue and margins.

Near term (days to 1–3 months), the risk is a negative earnings-quality reaction despite headline sales growth. Over 6–18 months, value engineering and greater outsourcing could support margins, but may trade fixed-cost leverage for supplier dependence and quality-control risk. The bearish view is falsified by sustained recovery in core segment margins and cash generation excluding disposals; the bullish view is falsified by continued margin erosion, weak project conversion, or discounting after the seasonal demand peak. Without valuation and peer-margin data, a directional pair trade is not well supported.

Key Decisions for Investors

• Avoid chasing the revenue beat; for existing exposure, consider trimming or hedging into strength until core profitability—not reported net income—stabilizes.
• Make the next 1–3 months an evidence window: track Unitary Products and Electro-Mechanical segment EBIT margins, project execution, and post-summer channel inventory/discounting. Persistent declines would strengthen the underweight case.
• Treat the net-cash position as a resilience buffer, not proof of recurring cash-flow improvement; verify operating cash flow and working-capital movements excluding MedTech and property-sale proceeds.
• Keep data-center growth as an alert, not a near-term valuation anchor. Reassess if disclosed order conversion and segment economics substantiate the expansion plan; reconsider the cautious stance after consecutive quarters of core margin recovery.